AzTrials
AzTrials

StrokeNCT05520489

Upper Limb Rehabilitation in First Year After Stroke Using Modern Treatment Strategies - a Single Case Study

A study testing Repetitive Transcranial Magnetic stimulation, Robot Assisted Therapy and Enhanced upper limb therapy programme in people with Stroke, run by Satasairaala at 1 site in Finland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Stroke is a major cause of disability in worldwide, causing billions of euros direct and indirect costs to the community. Upper limb motor dysfunction is seen in about 50% stroke survivors. Upper extremity paresis is identified as a strong component for performing activities of daily living (ADL) (Veerbeek 2011). Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke
What is being tested?
Repetitive Transcranial Magnetic stimulation, Robot Assisted Therapy and Enhanced upper limb therapy programme
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteFinland
Study dates
1 Jan 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adults with hemiparesis/hemiplegia due to stroke (ischaemic or haemorrhagic)
  • stroke diagnose within the previous 2-9 months (subacute phase)
  • upper extremity Fugl-Meyer (FMA) motor score < 56.

Who cannot join

  • patient is unable to understand instructions
  • transcranial magnetic stimulation contraindications (Rossi 2009, Rossini 2015)
  • concurrent medical condition likely to worsen functional status within 6 months

Trial locations and contacts

1 site in 1 country.

Finland1 site, 1 recruiting
  • dep of physical medicine and rehabilitation Satasairaala

    Pori, 28100

    hannu v heikkilä, +358401493233, hannu.heikkila@satasairaala.fi

    aet ristmagi, +358730662801, rehabtjanster@hotmail.com

    Recruiting

Other trials in Finland

About this study

Official title: Upper Limb Rehabilitation in First Year After Stroke Using Modern Treatment Strategies (rTMS, Robot Assisted Training and Intensive Motor Training ) - a Single Case Study

Stroke is a major cause of disability in worldwide, causing billions of euros direct and indirect costs to the community. Upper limb motor dysfunction is seen in about 50% stroke survivors. Upper extremity paresis is identified as a strong component for performing activities of daily living (ADL) (Veerbeek 2011). Upper-limb rehabilitation is crucial during the first three to six months since the onset of stroke because the motor and ADL-performance recovery of stroke survivors declines afterward (Kwakkel \& Kollen, 2013, Wade et al., 1983). The main advantages of using robot-assisted therapy are to deliver high-dosage and high-intensity training (Sivan et al., 2011). Robot-assisted training enables a greater number of repetitive tasks to be practised in a consistent and controllable manner. A dose of greater than 20 h of repetitive task training improves upper limb motor recovery following a stroke (Pollock 2014) and, therefore, robot-assisted training has the potential to improve arm motor recovery after stroke.

Repetitive transcranial magnetic stimulation (rTMS) is the field of interest and is incorporated to stroke rehabilitation in many institutes. Low-frequency rTMS to the unaffected hemisphere could normalize the inhibitory imbalance between hemispheres (Adeyemo et al., 2012). The safety and application guidelines of transcranial magnetic stimulation were extensively reviewed by Rossi et al. (2009). It is opposed that there is no effect of rTMS alone on upper extremity (UE) disabilities, but rTMS in combination with another rehabilitation treatment potentiates the effect of the rehabilitation treatment alone with regards to UE impairment. There is inconclusive evidence that the combined treatment (rTMS + conventional rehabilitation) have effect on UE disabilities. Treatment effects have been described in acute, subacute and chronic stroke patients, though it is proposed, that there is lack of late subacute phase rTMS studies that used FMA for outcome measure (van Lieshout, 2019).

In this single-case study the investigators compare different rehabilitation modules - self exercising (baseline), robot assisted training, rTMS and intensive motor training guided by therapist, to improve the use of paretic hand. The aim of this study is to show if there is clinically relevant improvement of the motion or function of upper extremity in different treatment strategies and if any of these treatment is superior to self-training.

Read the detailed description

Introduction Stroke is a major cause of disability in worldwide, causing billions of euros direct and indirect costs to the community. Upper limb motor dysfunction is seen in about 50% stroke survivors. Upper extremity paresis is identified as a strong component for performing ADL (Veerbeek 2011, 1). Hemi-paretic upper extremity causes reduction of capacity to carry out different types of functional tasks like reaching, grasping and manipulation that may lead to difficulty in activities of daily life (Yavuser 2008, 2). Upper-limb rehabilitation is crucial during the first three to six months since the onset of stroke because the motor and ADL-performance recovery of stroke survivors declines afterward (Kwakkel \& Kollen, 2013, Wade et al., 1983) (3-4).

Improvement probably occurs through a complex combination of spontaneous and learning-dependent processes including: restitution, substitution, and compensation (Kwakkel et al., 2004; Langhorne et al., 2011)(5-6). Until the third month after stroke onset, a variable spontaneous neurological recovery can be considered a confounder of rehabilitation intervention (Kwakkel et al., 2006)(7). Progresses in functional outcome appearing after 3 months seem largely dependent on learning adaptation strategies (Kwakkel et al., 2004)(5). Evidence suggests that neurological repair through brain reorganization supporting true recovery or, alternatively through compensation, may also take place in the subacute and chronic phase after stroke (Krakauer, 2006)(8).

Since upper limb paresis is shown to be major factor for performing ADL activities and is strongly related to independence in self-care, there is urgent need to find methods to improve the function of paretic upper limb.

Motor training, functional training and goal-setting are traditional rehabilitation methods that are widely used and are often the treatment standard for stroke patients.

In the recent Cochrane review it was concluded that robot assisted therapy can improve activities of daily living, arm function, and muscle strength of the paretic arm (Mehrholz, 2018)(9). The main advantages of using robot-assisted therapy are to deliver high-dosage and high-intensity training (Sivan et al., 2011)(10). Robot-assisted training enables a greater number of repetitive tasks to be practised in a consistent and controllable manner. Repetitive task training is known to drive Hebbian plasticity, where wiring of pathways that are coincidently active is strengthened (Hallett 1999, Hebb 1949)(11,12). A dose of greater than 20 h of repetitive task training improves upper limb motor recovery following a stroke (Pollock 2014)(13) and, therefore, robot-assisted training has the potential to improve arm motor recovery after stroke.

Repetitive transcranial magnetic stimulation (rTMS) is the field of interest and is incorporated to stroke rehabilitation in many institutes. Low-frequency rTMS (inhibitory stimulation, 1 Hz) to the unaffected hemisphere could normalize the inhibitory imbalance between hemispheres (Adeyemo et al., 2012)(14). The safety and application guidelines of transcranial magnetic stimulation were extensively reviewed by Rossi et al. (2009)(15). It is opposed that there is no effect of rTMS alone on upper extremity (UE) disabilities, but rTMS in combination with another rehabilitation treatment (occupational therapy, physiotherapy, motor training) potentiates the effect of the rehabilitation treatment alone with regards to UE impairment. There is inconclusive evidence that the combined treatment (rTMS + conventional rehabilitation) have effect on UE disabilities. Treatment effects have been described in acute, subacute and chronic stroke patients, though it is proposed, that there is lack of late subacute phase rTMS studies that used Fugl-Meyer Assessment (FMA) for outcome measure (van Lieshout, 2019, 27).

In this single-case study the investigators compare different rehabilitation modules - self exercising (baseline), robot assisted training, rTMS and intensive motor training guided by therapist, to improve the use of paretic hand. In this study we want to investigate, if there is clinically relevant improvement of the motion or function of upper extremity in different treatment strategies and if there are any of these treatment superior to self-training.

Methods Study design A single-case design was chosen since it is sensitive to individual improvement and is of appropriate scope for a small-scale rehabilitation study (Zhan, 2001, Lobo, 2017)(16, 17). The single-case design employed in this study consisted of a 3 week baseline phase (phase A), 3 different intervention phases - intensive guided UE motor training, rTMS and robot assisted UE training (phase B, C and D in randomized order, each 3 weeks long), second baseline phase (phase E) as well as a 2 month follow up. Baseline phase included self-practicing without any additional UE therapy/(+TAU). The assessment was performed before and after every phase and in 2 months follow up. All participants consented before trial procedures. This study is part of the quality register study of the Department of physical medicine and rehabilitation in Satasairaala (The West Coast Quality Register https://www.lansirannikonlaaturekisteri.fi ) and the trial was approved by Satasairaala (SATSHP/697/13.01/2020).

Participants All patients were treated in Satasairaala rehabilitation ward with a multidisciplinary rehabilitation team after acute management with the stroke diagnosis and had remarkable UE paresis. After discharge, all patients were followed up in out-patient rehabilitation clinic and everyone had an individual rehabilitation plan. During hospital stay and follow up the improvement of overall function and specifically UE function were assessed. Patient was offered to participate the study when the UE functional improvement has significantly slowed down or stopped (to rule out rapid spontaneous improvement), patient met the inclusion criteria and voluntarily wanted to participate.

Interventions Repetitive Transcranial Magnetic stimulation Participants received 15 sessions (15 daily session - Monday to Friday) of active rTMS over the 'hotspot" M1 area of the unaffected hemisphere leading to a response in the contralateral thenar muscle using Visor2-navigation system and MagstimRapid -magnetic stimulator. "Hot spot" localization was performed by stimulation with 50%:n intensity and found the maximum response area, where the coil was placed using the navigator cursor. The motor threshold was found using Maximum-Likelihood Strategy -algorithm of MTAT system.

Low frequency rTMS was applied at 80-90% resting motor threshold (rMT) intensity, 1 Hz, 600+600 pulses, inbetween 10 minutes break. Intensity was increased after each 2-3 treatment to keep motor threshold 90%.

Robot Assisted Therapy This was delivered using the Diego and Pablo (Tyromotion GmBH) robotic gym system. Participants receive robot-assisted training for up to 60 min per day, four days per week for 3 weeks, in addition to usual care. Robotic devices enable 3D interactive exercising, using weight reducing system in Diego and fine motor training in Pablo. Exercises can be one- or two-handed and/or symmetrical. Patient performs 150-400 repetitions in one therapy session. Estimated time is 2-3 minutes per one exercise section. Standard "minimum" program includes 4 games: "swimming", "shooting", "ship" and "apple orchard". The therapist instructs the patient and assure the position of trunk and shoulder girdle.

Enhanced upper limb therapy programme Exercises were performed by using different objects for task orientated movements. The therapist provided assistance as needed and encouraged participants to complete the tasks. Training was divided to 3 sessions for fine motor training and complex training and 1 session for shoulder girdle and complex training per week for 3 weeks, in addition to usual care. Each session lasts 1 hour and estimated time is 2-5 min to each exercise section.

Statistical Analysis All statistical analyses are carried out in the Statistical Package for Social Sciences (SPSS.21). The alpha level for significance was set at P<0.05. Between groups data will be examined using analysis of variances (ANOVAs). Demographic variables are compared using a t-test or chi-squared test for continuous and categorical variables, respectively. ANOVA will be utilized for the primary outcome FMA, joint movement, strength and shoulder proprioception and the secondary outcomes of the HRQoL.

Results Earlier studies indicate, that rTMS improves UE motor function compared to sham TMS (Hosomi, 28). Robot-assisted training is suggested be slightly superior compared to convention upper limb therapy in improving arm capacity and activities of daily living (Chen, 29). Cochrane review states that robot-assisted therapy might improve activities of daily living, arm function, and arm muscle strength of stroke survivors (Mehrholz, 9).

Conditions
Stroke
Being tested
Repetitive Transcranial Magnetic stimulation, Robot Assisted Therapy, Enhanced upper limb therapy programme
Keywords
rTMS, Robot Assisted Therapy, strokerehabilitation
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Repetitive Transcranial Magnetic stimulationDevice

    Participants received 15 sessions (15 daily session - Monday to Friday) of active rTMS over the 'hotspot" M1 area of the unaffected hemisphere leading to a response in the contralateral thenar muscle using Visor2-navigation system and MagstimRapid -magnetic stimulator. . "Hot spot" localization was performed by stimulation with 50%:n intensity and found the maximum response area, where the coil was placed using the navigator cursor. The motor threshold was found using Maximum-Likelihood Strategy -algorithm of MTAT system.

    Low frequency rTMS was applied at 80-90% resting motor threshold (rMT) intensity, 1 Hz, 600+600 pulses, inbetween 10 minutes break. Intensity was increased after each 2-3 treatment to keep motor threshold 90%.

  • Robot Assisted TherapyDevice

    This was delivered using the Diego and Pablo (Tyromotion GmBH) robotic gym system. Participants receive robot-assisted training for up to 60 min per day, four days per week for 3 weeks, in addition to usual care. Robotic devices enable 3D interactive exercising, using weight reducing system in Diego and fine motor training in Pablo. Exercises can be one- or two-handed and/or symmetrical. Patient performs 150-400 repetitions in one therapy session. Estimated time is 2-3 minutes per one exercise section. Standard "minimum" program includes 4 games: "swimming", "shooting", "ship" and "apple orchard". The therapist instructs the patient and assure the position of trunk and shoulder girdle.

  • Enhanced upper limb therapy programmeOther

    Exercises were performed by using different objects for task orientated movements. The therapist provided assistance as needed and encouraged participants to complete the tasks. Training was divided to 3 sessions for fine motor training and complex training and 1 session for shoulder girdle and complex training per week for 3 weeks, in addition to usual care. Each session lasts 1 hour and estimated time is 2-5 min to each exercise section.

Study groups in NCT05520489
Study groupRoleWhat they receive
treatment as usual, physiotherapyActive comparatorExercises were performed by using different objects for task orientated movements. The therapist provided assistance as needed and encouraged participants to complete the tasks. Training was divided to 3 sessions for fine motor training and complex training and 1 session for shoulder girdle and complex training per week for 3 weeks, in addition to usual care. Each session lasts 1 hour and estimated time is 2-5 min to each exercise section
Receives: Device: Repetitive Transcranial Magnetic stimulation; Device: Robot Assisted Therapy
Transcranial magnetic stimulationActive comparatorParticipants received 15 sessions (15 daily session - Monday to Friday) of active rTMS over the 'hotspot" M1 area of the unaffected hemisphere leading to a response in the contralateral thenar muscle using Visor2-navigation system and MagstimRapid -magnetic stimulator. Low frequency rTMS was applied at 80-90% resting motor threshold (rMT) intensity, 1 Hz, 600+600 pulses, inbetween 10 minutes break. Intensity was increased after each 2-3 treatment to keep motor threshold 90%.
Receives: Device: Robot Assisted Therapy; Other: Enhanced upper limb therapy programme
robot assisted trainingActive comparatorThis was delivered using the Diego and Pablo (Tyromotion GmBH) robotic gym system. Participants receive robot-assisted training for up to 60 min per day, four days per week for 3 weeks, in addition to usual care. Robotic devices enable 3D interactive exercising, using weight reducing system in Diego and fine motor training in Pablo. Exercises can be one- or two-handed and/or symmetrical. Patient performs 150-400 repetitions in one therapy session. Estimated time is 2-3 minutes per one exercise section. Standard "minimum" program includes 4 games: "swimming", "shooting", "ship" and "apple orchard". The therapist instructs the patient and assure the position of trunk and shoulder girdle.
Receives: Device: Repetitive Transcranial Magnetic stimulation; Other: Enhanced upper limb therapy programme

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Assessment

    Upper extremity motor, sensory, pain and movement assessment with higher value showing better results.

    Measured: 3 weeks

  2. active range of motion in shoulder joint, elbow, wrist

    measured either by robotic device or goniometer; strength of hand and fingers (Jamar, Pablo) and shoulder proprioception (when the active movement of shoulder joint enabled assessment with laserpointer and target).

    Measured: 3 weeks

Secondary outcomes (6)
  1. Quality of life Eq-5D

    5 dimension self-assessment tool, calculated index from 0 to 1, where 1 is better quality of life

    Measured: 4 months

  2. Quality of life Eq-5D Visual Analogue Scale

    Self-assessed number between 0 and 100, where 100 is the best score for general health

    Measured: 4 months

  3. International Classification of Function 15 Dimensions

    15 dimensions of different health subdivisions, calculated as index between 0 and 1 where 1 is better outcome.

    Measured: 4 months

  4. World Health Organization Disability Assessment Schedule 2.0

    12 dimension self-assessment tool, calculated index between 0 and 1 where 1 is better outcome

    Measured: 4 months

  5. Hospital Anxiety and Depression Score

    Self-assessed Depression and Anxiety score between 0 and 21 each, with 21 the most depressed and anxious.

    Measured: 4 months

  6. Life Satisfaction

    11 dimension self-assessment tool, each dimension assessed from 1 to 6, where 1 means not satisfied at all and 6 means very satisfied.

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2022
  2. Study start1 Jan 2022
  3. Primary completion31 May 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05520489
Sponsor's protocol ID
satsairaalrehaba
Status last verified
Aug 2022
First submitted
22 Aug 2022
Last updated
30 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Repetitive Transcranial Magnetic stimulation, Robot Assisted Therapy and Enhanced upper limb therapy programme in people with Stroke, run by Satasairaala at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Assessment (time frame: 3 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in